# Heme Arginate in Functional Magnetic Resonance Imaging (fMRI)

> **NCT01461512** · PHASE2 · UNKNOWN · sponsor: **MWolzt** · enrollment: 16 (actual)

## Conditions studied

- Ischemia-reperfusion Injury

## Interventions

- **DRUG:** heme arginate administration
- **DRUG:** Placebo administration

## Key facts

- **NCT ID:** NCT01461512
- **Lead sponsor:** MWolzt
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** 2011-08
- **Final completion:** 2011-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2011-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01461512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01461512, "Heme Arginate in Functional Magnetic Resonance Imaging (fMRI)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01461512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*